首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2055300

基因檢測市場：按檢測類型、技術、應用、患者年齡層、最終用戶和地區分類

Hereditary Testing Market, By Test Type, By Technology, By Application, By Patient Age Group, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，基因檢測市場規模將達85億美元，到2033年將達到152.2億美元。預計從2026年到2033年，該市場將以8.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	85億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.70%	2033年市場規模預測：	152.2億美元

近年來，受基因技術進步和人們對疾病早期檢測與預防重要性認知不斷提高的推動，全球基因檢測市場經歷了顯著成長。基因檢測透過分析個體的DNA來識別可能增加其患有某些遺傳疾病風險的基因變異。該市場涵蓋多種基因檢測，包括癌症、心血管疾病、神經系統疾病和罕見遺傳疾病的檢測。隨著我們對疾病遺傳基礎的理解不斷加深，對基因檢測的需求預計將持續成長，進一步推動市場發展。此外，面向消費者的基因檢測套組的普及和個人化醫療方法的日益廣泛應用也促進了市場擴張。

市場動態

全球基因檢測市場受多種關鍵促進因素、限制因素和機會的影響。其中一個主要促進因素是全球遺傳疾病盛行率的不斷上升，以及人們對早期檢測和預防重要性的日益重視。基因定序技術的進步，例如次世代定序（NGS），使基因檢測更加普及和經濟實惠，進一步推動了市場成長。此外，利用基因資訊制定個人化治療方案的個人化醫療方法的日益普及，也為基因檢測市場創造了巨大的機會。然而，該市場也面臨一些限制因素，包括基因檢測高成本、保險報銷範圍有限，以及關於基因資訊隱私和歧視的倫理問題。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球基因檢測市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球基因檢測市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球基因檢測市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Illumina, Inc.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Agilent Technologies, Inc.
Fulgent Genetics, Inc.
Genomic Health, Inc.
Invitae Corporation
Roche Diagnostics
Siemens Healthineers
BGI Genomics
Quest Diagnostics
PerkinElmer, Inc.
Eurofins Scientific
ArcherDX
Color Genomics

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8033

Hereditary Testing Market is estimated to be valued at USD 8.50 Bn in 2026 and is expected to reach USD 15.22 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.50 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.70%	2033 Value Projection:	USD 15.22 Bn

The global hereditary testing market has witnessed significant growth in recent years, driven by advancements in genetic technology and increasing awareness about the importance of early disease detection and prevention. Hereditary testing involves analyzing an individual's DNA to identify genetic variations that may increase the risk of developing certain inherited disorders. This market encompasses a wide range of genetic tests, including those for cancer, cardiovascular diseases, neurological disorders, and rare genetic conditions. As the understanding of the genetic basis of diseases continues to expand, the demand for hereditary testing is expected to rise, fueling market growth. Moreover, the increasing availability of direct-to-consumer genetic testing kits and the growing adoption of personalized medicine approaches are further contributing to the market's expansion.

Market Dynamics

The global hereditary testing market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of genetic disorders worldwide, coupled with the rising awareness about the importance of early detection and prevention. Advancements in genetic sequencing technologies, such as next-generation sequencing (NGS), have made genetic testing more accessible and affordable, further driving market growth. Moreover, the growing adoption of personalized medicine approaches, which rely on genetic information to tailor treatment plans, is creating significant opportunities for the hereditary testing market. However, the market also faces certain restraints, such as the high cost of genetic testing, limited reimbursement policies, and ethical concerns surrounding genetic privacy and discrimination.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hereditary testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Fulgent Genetics, Inc., Genomic Health, Inc., Invitae Corporation, Roche Diagnostics, Siemens Healthineers, BGI Genomics, Quest Diagnostics, PerkinElmer, Inc., Eurofins Scientific, ArcherDX, and Color Genomics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hereditary testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hereditary testing market

Market Segmentation

Test Type Insights (Revenue, USD Bn, 2021 - 2033)
Predictive Testing
Diagnostic Testing
Carrier Testing
Prenatal Testing
Newborn Screening
Preimplantation Genetic Diagnosis (PGD)
Pharmacogenomic Testing
Technology Insights (Revenue, USD Bn, 2021 - 2033)
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Fluorescence In Situ Hybridization (FISH)
Sanger Sequencing
Array Comparative Genomic Hybridization (aCGH)
Application Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Cardiovascular Diseases
Neurology
Metabolic Disorders
Rare Diseases
Reproductive Health
Others
Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
Pediatric
Adult
Geriatric
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Specialty Clinics
Diagnostic Laboratories
Research Institutions
Home Care Settings
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Illumina, Inc.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Agilent Technologies, Inc.
Fulgent Genetics, Inc.
Genomic Health, Inc.
Invitae Corporation
Roche Diagnostics
Siemens Healthineers
BGI Genomics
Quest Diagnostics
PerkinElmer, Inc.
Eurofins Scientific
ArcherDX
Color Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Hereditary Testing Market, By Test Type
- Global Hereditary Testing Market, By Technology
- Global Hereditary Testing Market, By Application
- Global Hereditary Testing Market, By Patient Age Group
- Global Hereditary Testing Market, By End User
- Global Hereditary Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Hereditary Testing Market, By Test Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Predictive Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Carrier Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Preimplantation Genetic Diagnosis (PGD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pharmacogenomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Hereditary Testing Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Array Comparative Genomic Hybridization (aCGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Hereditary Testing Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Hereditary Testing Market, By Patient Age Group, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Hereditary Testing Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Hereditary Testing Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fulgent Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genomic Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ArcherDX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Color Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies